Sam N Scott1,2, Federico Y Fontana2, Thomas Züger1,3, Markus Laimer1, Christoph Stettler1. 1. Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism Bern University Hospital University of Bern Bern Switzerland. 2. Team Novo Nordisk Professional Cycling Team Atlanta GA USA. 3. Department of Management, Technology, and Economics ETH Zurich Zurich Switzerland.
Abstract
Introduction: The COVID-19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person-to-person contact is to offer remote services (telemedicine). This study aimed to (1) gather real-time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open-access web-based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA1c. Results: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty-two per cent reported no fundamental change in their medical follow-up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty-eight per cent received remote care through telephone (72%) or video-calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA1c, was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA1c > 9% rated telemedicine not useful compared to those with lower HbA1c, while 20% of females with an HbA1c > 9% rated it not useful (χ2 = 14.2, P = .0016). Conclusion: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
Introduction: The COVID-19 pandemic has forced rapid reconsideration as to the way in which health care is delivered. One potential means to provide care while avoiding unnecessary person-to-person contact is to offer remote services (telemedicine). This study aimed to (1) gather real-time information on the use and perception of telemedicine in people living with type 1 diabetes and (2) assess the challenges, such as restricted access to health care and/or medical supplies. Methods: An anonymous questionnaire was widely distributed between 24 March and 5 May 2020 using an open-access web-based platform. Data were analysed descriptively, and results were stratified according to age, sex and HbA1c. Results: There were 7477 survey responses from individuals in 89 countries. Globally, 30% reported that the pandemic had affected their healthcare access due to cancelled physical appointments with their healthcare providers. Thirty-two per cent reported no fundamental change in their medical follow-up during this period, with 9% stating that no personal contact was established with their doctors over the duration of the study. Twenty-eight per cent received remote care through telephone (72%) or video-calls (28%). Of these, 86% found remote appointments useful and 75% plan to have remote appointments in the future. Glucose control, indicated by HbA1c, was positively associated with positive perception of telemedicine. In males, 45% of respondents with an HbA1c > 9% rated telemedicine not useful compared to those with lower HbA1c, while 20% of females with an HbA1c > 9% rated it not useful (χ2 = 14.2, P = .0016). Conclusion: Remote appointments have largely been perceived as positive in people with type 1 diabetes with the majority (75%) stating that they would consider remote appointments beyond the pandemic. Age and level of education do not appear to influence perception of telemedicine, whereas poor glucose control, particularly in males, seems to negatively affect perception.
Authors: Keshia R De Guzman; Centaine L Snoswell; Monica L Taylor; Buddhika Senanayake; Helen M Haydon; Jennifer A Batch; Anthony C Smith; Liam J Caffery Journal: Diabetes Technol Ther Date: 2020-03-04 Impact factor: 6.118
Authors: Andrew Farmer; Oliver Gibson; Paul Hayton; Kathryn Bryden; Christina Dudley; Andrew Neil; Lionel Tarassenko Journal: Inform Prim Care Date: 2005
Authors: Danny C Duke; Samantha Barry; David V Wagner; Jane Speight; Pratik Choudhary; Michael A Harris Journal: Lancet Diabetes Endocrinol Date: 2017-08-31 Impact factor: 32.069
Authors: Marwan Bakhach; Mark W Reid; Elizabeth A Pyatak; Cari Berget; Cindy Cain; John Fred Thomas; Georgeanna J Klingensmith; Jennifer K Raymond Journal: Diabetes Educ Date: 2019-06-27 Impact factor: 2.140
Authors: Julia A Critchley; Iain M Carey; Tess Harris; Stephen DeWilde; Fay J Hosking; Derek G Cook Journal: Diabetes Care Date: 2018-08-13 Impact factor: 19.112
Authors: Marta Bassi; Marina Francesca Strati; Stefano Parodi; Simone Lightwood; Clara Rebora; Francesca Rizza; Giuseppe d'Annunzio; Nicola Minuto; Mohamad Maghnie Journal: Front Public Health Date: 2022-03-22
Authors: Sultan F Magliah; Ahmad S Alsabban; Haneen A Turkistani; Bahaa A Abulaban; Abdulaziz H Alsharif; Sarah S Alsharif; Hawazen A Zarif Journal: Diabetes Metab Syndr Date: 2021-06-12